Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Tayabali, Azam F ^a   Nguyen, Kathy C ^a   Shwed, Philip S ^a   Crosthwait, Jennifer ^a   Coleman, Gordon ^a   Seligy, Verner L ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MEROPENEM; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TRIMETHOPRIM; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER GUILLOUAIE; ACINETOBACTER HAEMOLYTICUS; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ACINETOBACTER VENETIANUS; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL CULTURE; CELL INTERACTION; CELL KILLING; CELL PROLIFERATION; COCULTURE; COLON MUCOSA; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EPITHELIUM CELL; EPSA GENE; GENE MUTATION; GYRA GENE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OMPA GENE; PARC GENE; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SPECIES DIFFERENTIATION; ACINETOBACTER INFECTION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECT; ERYTHROCYTE; GENETICS; HOST PATHOGEN INTERACTION; MICROBIOLOGY; MOLECULAR GENETICS; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; SEQUENCE ALIGNMENT; SHEEP;

ACINETOBACTER; BACTERIA (MICROORGANISMS); MAMMALIA;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CELL SURVIVAL; DRUG RESISTANCE, BACTERIAL; ERYTHROCYTES; GENES, BACTERIAL; HEMOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; PHAGOCYTOSIS; SEQUENCE ALIGNMENT; SHEEP;

EID: 84861417670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037024     Document Type: Article

References (80)

1. de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, et al. (2010) Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii? PLoS ONE 5: e10732 doi:10.1371/journal.pone.0010732.
2. Euzéby JP, (1997) List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol 47: 590-592.
3. Dijkshoorn L, Nemec A, (2008) The Diversity of the Genus Acinetobacter. In: Gerischer U, editors. Acinetobacter molecular microbiology Horizon Scientific Press.
4. Luckarift HR, Sizemore SR, Farrington KE, Fulmer PA, Biffinger JC, et al. (2011) Biodegradation of medium chain hydrocarbons by Acinetobacter venetianus 2AW immobilized to hair-based adsorbent mats. Biotechnology Progress. Available:http://www.ncbi.nlm.nih.gov/pubmed/21948333. Accessed 28 October 2011.
5. Abdel-El-Haleem D, (2003) Acinetobacter: environmental and biotechnological applications. African Journal of Biotechnology 2: 71-74.
6. Singh GB, Gupta S, Srivastava S, Gupta N, (2011) Biodegradation of Carbazole by Newly Isolated Acinetobacter spp. Bull Environ Contam Toxicol 87: 522-526 doi:10.1007/s00128-011-0382-0.
7. Jung J, Noh J, Park W, (2011) Physiological and metabolic responses for hexadecane degradation in Acinetobacter oleivorans DR1. J Microbiol 49: 208-215 doi:10.1007/s12275-011-0395-8.
8. Zhao Z, Selvam A, Wong JW-C, (2011) Synergistic effect of thermophilic temperature and biosurfactant produced by Acinetobacter calcoaceticus BU03 on the biodegradation of phenanthrene in bioslurry system. J Hazard Mater 190: 345-350 doi:10.1016/j.jhazmat.2011.03.042.
9. Dams-Kozlowska H, Mercaldi MP, Panilaitis BJ, Kaplan DL, (2008) Modifications and applications of the Acinetobacter venetianus RAG-1 exopolysaccharide, the emulsan complex and its components. Appl Microbiol Biotechnol 81: 201-210 doi:10.1007/s00253-008-1664-2.
10. Snellman EA, Sullivan ER, Colwell RR, (2002) Purification and properties of the extracellular lipase, LipA, of Acinetobacter sp. RAG-1. Eur J Biochem 269: 5771-5779.
11. Su W-T, Chen W-J, Lin Y-F, (2009) Optimizing emulsan production of A. venetianus RAG-1 using response surface methodology. Appl Microbiol Biotechnol 84: 271-279 doi:10.1007/s00253-009-1957-0.
12. Vaneechoutte M, Tjernberg I, Baldi F, Pepi M, Fani R, et al. (1999) Oil-degrading Acinetobacter strain RAG-1 and strains described as "Acinetobacter venetianus sp. nov." belong to the same genomic species. Res Microbiol 150: 69-73.
13. Bifulco JM, Shirey JJ, Bissonnette GK, (1989) Detection of Acinetobacter spp. in rural drinking water supplies. Appl Environ Microbiol 55: 2214-2219.
14. Simões LC, Simões M, Vieira MJ, (2008) Intergeneric coaggregation among drinking water bacteria: evidence of a role for Acinetobacter calcoaceticus as a bridging bacterium. Appl Environ Microbiol 74: 1259-1263 doi:10.1128/AEM.01747-07.
15. Giamarellou H, Antoniadou A, Kanellakopoulou K, (2008) Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 32: 106-119 doi:10.1016/j.ijantimicag.2008.02.013.
16. Gootz TD, Marra A, (2008) Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther 6: 309-325 doi:10.1586/14787210.6.3.309.
17. Keen EF 3rd, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, et al. (2010) Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns 36: 819-825 doi:10.1016/j.burns.2009.10.013.
18. Luna CM, Aruj PK, (2007) Nosocomial Acinetobacter pneumonia. Respirology 12: 787-791 doi:10.1111/j.1440-1843.2007.01147.x.
19. Peleg AY, Seifert H, Paterson DL, (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582 doi:10.1128/CMR.00058-07.
20. Rathinavelu S, Zavros Y, Merchant JL, (2003) Acinetobacter lwoffii infection and gastritis. Microbes Infect 5: 651-657.
21. Apisarnthanarak A, Kiratisin P, Thongphubeth K, Yuakyen C, Mundy LM, (2007) Pseudo-outbreak of Acinetobacter lwoffii infection in a tertiary care center in Thailand. Infect Control Hosp Epidemiol 28: 637-639 doi:10.1086/513620.
22. Cayô R, Yañez San Segundo L, Pérez del Molino Bernal IC, García de la Fuente C, Bermúdez Rodríguez MA, et al. (2011) Bloodstream infection caused by Acinetobacter junii in a patient with acute lymphoblastic leukaemia after allogenic haematopoietic cell transplantation. J Med Microbiol 60: 375-377 doi:10.1099/jmm.0.024596-0.
23. Hung Y-T, Lee Y-T, Huang L-J, Chen T-L, Yu K-W, et al. (2009) Clinical characteristics of patients with Acinetobacter junii infection. J Microbiol Immunol Infect 42: 47-53.
24. Smith AW, Alpar KE, (1991) Immune response to Acinetobacter calcoaceticus infection in man. J Med Microbiol 34: 83-88.
25. Chen T-L, Siu L-K, Lee Y-T, Chen C-P, Huang L-Y, et al. (2008) Acinetobacter Baylyi as a Pathogen for Opportunistic Infection. J Clin Microbiol 46: 2938-2944 doi:10.1128/JCM.00232-08.
26. Pellegrino FLPC, Vieira VV, Baio PVP, dos Santos RMR, dos Santos ALA, et al. (2011) Acinetobacter soli as a cause of bloodstream infection in a neonatal intensive care unit. J Clin Microbiol 49: 2283-2285 doi:10.1128/JCM.00326-11.
27. Gordon NC, Wareham DW, (2010) Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219-226 doi:10.1016/j.ijantimicag.2009.10.024.
28. Livermore DM, (2003) The threat from the pink corner. Ann Med 35: 226-234.
29. Joly-Guillou M-L, (2005) Clinical impact and pathogenicity of Acinetobacter. Clinical microbiology and infection the official publication of the European Society of Clinical Microbiology and Infectious Diseases 11: 868-873.
30. Ong CWM, Lye DCB, Khoo KL, Chua GSW, Yeoh SF, et al. (2009) Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 14: 1200-1205 doi:10.1111/j.1440-1843.2009.01630.x.
31. Regalado NG, Martin G, Antony SJ, (2009) Acinetobacter lwoffii: bacteremia associated with acute gastroenteritis. Travel Med Infect Dis 7: 316-317 doi:10.1016/j.tmaid.2009.06.001.
32. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T, (2007) Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 26: 857-868 doi:10.1007/s10096-007-0365-6.
33. Hu J, Robinson JL, (2010) Systematic review of invasive Acinetobacter infections in children. Can J Infect Dis Med Microbiol 21: 83-88.
34. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, et al. (2010) Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 50: 1611-1616 doi:10.1086/652759.
35. Moreira Silva G, Morais L, Marques L, Senra V, (2012) Acinetobacter community-acquired pneumonia in a healthy child. Revista Portuguesa De Pneumologia 18: 96-98 doi:10.1016/j.rppneu.2011.07.006.
36. Ozaki T, Nishimura N, Arakawa Y, Suzuki M, Narita A, et al. (2009) Community-acquired Acinetobacter baumannii meningitis in a previously healthy 14-month-old boy. J Infect Chemother 15: 322-324 doi:10.1007/s10156-009-0704-x.
37. Tayabali AF, Seligy VL, (2000) Human cell exposure assays of Bacillus thuringiensis commercial insecticides: production of Bacillus cereus-like cytolytic effects from outgrowth of spores. Environ Health Perspect 108: 919-930.
38. Tayabali AF, Seligy VL, (1997) Cell integrity markers for in vitro evaluation of cytotoxic responses to bacteria-containing commercial insecticides. Ecotoxicol Environ Saf 37: 152-162 doi:10.1006/eesa.1997.1525.
39. Tayabali AF, Nguyen KC, Seligy VL, (2011) Early murine immune responses from endotracheal exposures to biotechnology-related Bacillus strains. Toxicological & Environmental Chemistry 93: 314-331 doi:10.1080/02772248.2010.526784.
40. Choi CH, Lee JS, Lee YC, Park TI, Lee JC, (2008) Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiology 8: 216 doi:10.1186/1471-2180-8-216.
41. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, et al. (2004) PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 10: BR180-184.
42. Gohl O, Friedrich A, Hoppert M, Averhoff B, (2006) The thin pili of Acinetobacter sp. strain BD413 mediate adhesion to biotic and abiotic surfaces. Appl Environ Microbiol 72: 1394-1401 doi:10.1128/AEM.72.2.1394-1401.2006.
43. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, et al. (2006) Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 157: 360-366 doi:10.1016/j.resmic.2005.09.011.
44. Choi CH, Hyun SH, Kim J, Lee YC, Seol SY, et al. (2008) Nuclear translocation and DNAse I-like enzymatic activity of Acinetobacter baumannii outer membrane protein A. FEMS Microbiol Lett 288: 62-67 doi:10.1111/j.1574-6968.2008.01323.x.
45. Choi CH, Hyun SH, Lee JY, Lee JS, Lee YS, et al. (2008) Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cellular Microbiology 10: 309-319 doi:10.1111/j.1462-5822.2007.01041.x.
46. Lee JC, Oh JY, Kim KS, Jeong YW, Park JC, et al. (2001) Apoptotic cell death induced by Acinetobacter baumannii in epithelial cells through caspase-3 activation. APMIS 109: 679-684.
47. Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, et al. (2010) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78: 3993-4000 doi:10.1128/IAI.00366-10.
48. Kim SA, Yoo SM, Hyun SH, Choi CH, Yang SY, et al. (2008) Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response to Acinetobacter baumannii outer membrane protein A. FEMS Immunol Med Microbiol 54: 45-52 doi:10.1111/j.1574-695X.2008.00446.x.
49. Taylor D, Whatling C, Kearney JN, Matthews B, Holland KT, (1990) The effect of bacterial products on human fibroblast and keratinocyte detachment and viability. Br J Dermatol 122: 23-28.
50. Antunes LCS, Imperi F, Carattoli A, Visca P, (n.d.) Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity. PLoS One 6.doi:10.1371/journal.pone.0022674.
51. Gospodarek E, (1993) [Hemolytic properties of bacteria belonging to the Acinetobacter genus]. Med Dosw Mikrobiol 45: 317-322.
52. García A, Salgado F, Solar H, González CL, Zemelman R, et al. (1999) Some immunological properties of lipopolysaccharide from Acinetobacter baumannii. J Med Microbiol 48: 479-483.
53. Seligy VL, Beggs RW, Rancourt JM, Tayabali AF, (1997) Quantitative bioreduction assays for calibrating spore content and viability of commercial Bacillus thuringiensis insecticides. Journal of Industrial Microbiology and Biotechnology 18: 370-378 doi:10.1038/sj.jim.2900404.
54. Seligy, Rancourt, (1999) Antibiotic MIC/MBC analysis of Bacillus-based commercial insecticides: use of bioreduction and DNA-based assays. J Ind Microbiol Biotechnol 22: 565-574.
55. Reen, DJ, (1994) Enzyme-linked Immunosorbant Assay (ELISA). In: Walker JM, editors. Basic protein and peptide protocols Humana Press, Vol.
56. Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, et al. (2005) Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 7: 1127-1138 doi:10.1111/j.1462-5822.2005.00538.x.
57. Vila J, Ruiz J, Goñi P, Jimenez de Anta T, (1997) Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 39: 757-762.
58. Vila J, Ruiz J, Goñi P, Marcos A, Jimenez de Anta T, (1995) Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39: 1201-1203.
59. Fournier P-E, Vallenet D, Barbe V, Audic S, Ogata H, et al. (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2: e7 doi:10.1371/journal.pgen.0020007.
60. Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S, et al. (2008) Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS ONE 3: e1805 doi:10.1371/journal.pone.0001805.
61. Baldi F, Pepi M, Capone A, della Giovampaola C, Milanesi C,et al. Envelope glycosylation determined by lectins in microscopy sections of Acinetobacter venetianus induced by diesel fuel. Research in Microbiology 154: 417-424 doi:10.1016/S0923-2508(03)00128-1.
62. Tayabali AF, Nguyen KC, Seligy VL, (2011) Early murine immune responses from endotracheal exposures to biotechnology-related Bacillus strains. Toxicological & Environmental Chemistry 93: 314-331 doi:10.1080/02772248.2010.526784.
63. Bouvet PJM, Grimont PAD, (1986) Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter Baumannii Sp. Nov., Acinetobacter Haemolyticus Sp. Nov., Acinetobacter Johnsonii Sp. Nov., and Acinetobacter Junii Sp. Nov. and Emended Descriptions of Acinetobacter Calcoaceticus and Acinetobacter Lwoffii. Int J Syst Bacteriol 36: 228-240 doi:10.1099/00207713-36-2-228.
64. Lehmann V, (1973) HAEMOLYTIC ACTIVITY OF VARIOUS STRAINS OF ACINETOBACTER. Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology 81B: 427-432 doi:10.1111/j.1699-0463.1973.tb02226.x.
65. Lehmann V, (1971) HAEMOLYTIC ACTIVITY OF ACINETOBACTER CALCOACETICUS. Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology 79B: 61-66 doi:10.1111/j.1699-0463.1971.tb00033.x.
66. Vaneechoutte M, Nemec A, Musílek M, van der Reijden TJK, van den Barselaar M, et al. (2009) Description of Acinetobacter venetianus ex Di Celloet al. 1997 sp. nov. Int J Syst Evol Microbiol 59: 1376-1381 doi:10.1099/ijs.0.003541-0.
67. Kwon S-O, Gho YS, Lee JC, Kim SI, (2009) Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett 297: 150-156 doi:10.1111/j.1574-6968.2009.01669.x.
68. Coyne S, Courvalin P, Périchon B, (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55: 947-953 doi:10.1128/AAC.01388-10.
69. Neonakis IK, Spandidos DA, Petinaki E, (2011) Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents 37: 102-109 doi:10.1016/j.ijantimicag.2010.10.014.
70. Garnacho-Montero J, Amaya-Villar R, (2010) Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 23: 332-339 doi:10.1097/QCO.0b013e32833ae38b.
71. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55-65 doi:10.1172/JCI117676.
72. Eckmann L, Kagnoff MF, Fierer J, (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61: 4569-4574.
73. Palfreyman RW, Watson ML, Eden C, Smith AW, (1997) Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun 65: 617-622.
74. Schuerer-Maly CC, Eckmann L, Kagnoff MF, Falco MT, Maly FE, (1994) Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 81: 85-91.
75. Bianchi ME, (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5 doi:10.1189/jlb.0306164.
76. Dalpke A, Heeg K, (2002) Signal integration following Toll-like receptor triggering. Crit Rev Immunol 22: 217-250.
77. Vogel SN, Fitzgerald KA, Fenton MJ, (2003) TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3: 466-477 doi:10.1124/mi.3.8.466.
78. Werling D, Jungi TW, (2003) TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 91: 1-12.
79. Huttunen K, Hyvärinen A, Nevalainen A, Komulainen H, Hirvonen M-R, (2003) Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines. Environ Health Perspect 111: 85-92.
80. Utaisincharoen P, Kespichayawattana W, Anuntagool N, Chaisuriya P, Pichyangkul S, et al. (2003) CpG ODN enhances uptake of bacteria by mouse macrophages. Clin Exp Immunol 132: 70-75.